Atypical Meningioma
📧 Sign up to get email alerts when something new happens for Atypical Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]
Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not …
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers [Phase 2]
A Phase 2 trial of nivolumab in patients with recurrent select rare CNS cancers (medulloblastoma, ependymoma, pineal region tumors, choroid …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma [Phase 2]
Phase 2 trial of pembrolizumab for refractory atypical and anaplastic meningioma has terminated; results have been posted.